Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Por um escritor misterioso
Descrição
Unexpected Consequence of the Pandemic: MIS-C-Related Cardiac Issues
Current practices in pediatric hospital‐acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium - Research and Practice in Thrombosis and Haemostasis
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021
Full article: Thrombotic events and prophylactic anticoagulation in pediatric patients with COVID-19: a systematic review and meta-analysis
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 - Henderson - 2022 - Arthritis & Rheumatology - Wiley Online Library
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves - ScienceDirect
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19
PDF) How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C
de
por adulto (o preço varia de acordo com o tamanho do grupo)
